It’s hard to go wrong with either company, but one is more appealing. Viking Therapeutics (VKTX 5.43%) and Summit Therapeutics (SMMT 7.20%) are both up-and-coming biotechs…

The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug. Viking Therapeutics (VKTX 11.31%) stormed the stock market…

Eli Lilly (LLY) and Novo Nordisk (NVO) have become hot stocks over the past year thanks to their blockbuster GLP-1 drugs to treat obesity.Over the last…